 Calcium Channel Blockers
"Calcium Channel Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
| Descriptor ID |
D002121
|
| MeSH Number(s) |
D27.505.519.562.249 D27.505.954.411.192
|
| Concept/Terms |
Calcium Channel Blockers- Calcium Channel Blockers
- Blockers, Calcium Channel
- Channel Blockers, Calcium
- Calcium Channel Antagonists
- Antagonists, Calcium Channel
- Calcium Channel Blocking Drugs
Calcium Antagonists, Exogenous- Calcium Antagonists, Exogenous
- Antagonists, Exogenous Calcium
- Exogenous Calcium Inhibitors
- Exogenous Calcium Antagonists
- Exogenous Calcium Blockaders
- Calcium Blockaders, Exogenous
- Calcium Inhibitors, Exogenous
|
Below are MeSH descriptors whose meaning is more general than "Calcium Channel Blockers".
Below are MeSH descriptors whose meaning is more specific than "Calcium Channel Blockers".
This graph shows the total number of publications written about "Calcium Channel Blockers" by people in this website by year, and whether "Calcium Channel Blockers" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 | | 1996 | 3 | 3 | 6 | | 1997 | 1 | 3 | 4 | | 1998 | 3 | 3 | 6 | | 1999 | 2 | 1 | 3 | | 2000 | 2 | 0 | 2 | | 2001 | 2 | 1 | 3 | | 2002 | 0 | 1 | 1 | | 2003 | 2 | 1 | 3 | | 2004 | 1 | 0 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 2 | 1 | 3 | | 2007 | 0 | 3 | 3 | | 2008 | 1 | 2 | 3 | | 2009 | 0 | 2 | 2 | | 2010 | 0 | 2 | 2 | | 2011 | 2 | 3 | 5 | | 2012 | 0 | 2 | 2 | | 2013 | 0 | 2 | 2 | | 2014 | 1 | 3 | 4 | | 2015 | 2 | 1 | 3 | | 2016 | 3 | 3 | 6 | | 2017 | 3 | 2 | 5 | | 2018 | 1 | 3 | 4 | | 2019 | 0 | 5 | 5 | | 2020 | 1 | 0 | 1 | | 2021 | 1 | 1 | 2 | | 2022 | 0 | 3 | 3 | | 2023 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Calcium Channel Blockers" by people in Profiles.
-
Forlenza GP, Schamberger MS, Buckingham BA. Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes-Reply. JAMA. 2023 07 25; 330(4):380.
-
Mehrpour O, Hoyte C, Al Masud A, Biswas A, Schimmel J, Nakhaee S, Nasr MS, Delva-Clark H, Goss F. Deep learning neural network derivation and testing to distinguish acute poisonings. Expert Opin Drug Metab Toxicol. 2023 Jan-Jun; 19(6):367-380.
-
Smith SM, Winterstein AG, Gurka MJ, Walsh MG, Keshwani S, Libby AM, Hogan WR, Pepine CJ, Cooper-DeHoff RM. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network. J Am Heart Assoc. 2023 01 03; 12(1):e026652.
-
Gutierrez GC, Dayton C, Attridge RL, Smedley L, Saikumar H, Everett C, Rodriguez A, Varney S. Angiotensin II Use in Treatment of Refractory Shock Due to Benazepril and Amlodipine Toxic Ingestion. J Pharm Pract. 2024 Apr; 37(2):513-516.
-
Mehrpour O, Hoyte C, Delva-Clark H, Al Masud A, Biswas A, Schimmel J, Nakhaee S, Goss F. Classification of acute poisoning exposures with machine learning models derived from the National Poison Data System. Basic Clin Pharmacol Toxicol. 2022 Dec; 131(6):566-574.
-
Caton MT, Mark IT, Narsinh KH, Baker A, Cooke DL, Hetts SW, Dowd CF, Halbach VV, Higashida RT, Ko NU, Chung SA, Amans MR. Endovascular Therapy for Intracranial Giant Cell Arteritis : Systematic Review, Technical Considerations and the Effect of Intra-arterial Calcium Channel Blockers. Clin Neuroradiol. 2022 Dec; 32(4):1045-1056.
-
Sharma A, Nakade UP, Akash R, Yadav VP, Choudhury S, Jaitley P, Sharma V, Garg SK. Calcium signaling cascades differentially regulate PGF2a-induced myometrial contractions in water buffaloes (Bubalus bubalis). Naunyn Schmiedebergs Arch Pharmacol. 2021 08; 394(8):1651-1664.
-
Scholtes RA, van Baar MJB, Kok MD, Bjornstad P, Cherney DZI, Joles JA, van Raalte DH. Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors. Nephrology (Carlton). 2021 May; 26(5):377-390.
-
Feseha S, Timic Stamenic T, Wallace D, Tamag C, Yang L, Pan JQ, Todorovic SM. Global genetic deletion of CaV3.3 channels facilitates anaesthetic induction and enhances isoflurane-sparing effects of T-type calcium channel blockers. Sci Rep. 2020 12 09; 10(1):21510.
-
LaVallee C, Rascati KL, Gums TH. Antihypertensive agent utilization patterns among patients with uncontrolled hypertension in the United States. J Clin Hypertens (Greenwich). 2020 11; 22(11):2084-2092.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|